Literature DB >> 6767739

Antibody response to serogroup A and C meningococcal polysaccharide vaccines in infants born of mothers vaccinated during pregnancy.

J B McCormick, H H Gusmão, S Nakamura, J B Freire, J Veras, G Gorman, J C Feeley, P Wingo.   

Abstract

During the large epidemic of serogroups A and C meningococcal disease in Brazil, we studied the immunologic response to meningococcal polysaccharide vaccine in infants born to women vaccinated during pregnancy. Radioimmunoassay serum levels against serogroups A and C polysaccharide were more than threefold higher in vaccinated than in unvaccinated women at delivery. Cord blood levels were also threefold or higher in infants whose mothers were vaccinated while pregnant compared to infants born of unvaccinated mothers. Within 3 mo, the infants' A and C serum antibody levels declined by approximately 80%. When vaccinated at about 6 mo of age, infants born of vaccinated mothers had antibody responses to A and C polysaccharide vaccines indistinguishable from those born of unvaccinated mothers. The response did not vary with the trimester of vaccination. We conclude that the vaccination of pregnant women with groups A and C meningococcal polysaccharide vaccine does not produce immune tolerance in the subsequently born infants.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6767739      PMCID: PMC371447          DOI: 10.1172/JCI109768

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  12 in total

1.  Studies on pneumococcal polysaccharide. II. Mechanism involved in production of immunological paralysis by type I pneumococcal polysaccharide.

Authors:  O K STARK
Journal:  J Immunol       Date:  1955-02       Impact factor: 5.422

2.  Epidemic disease due to serogroup C Neisseria meningitidis in Saõ Paulo, Brazil.

Authors:  J Souza de Morais; R S Munford; J B Risi; E Antezana; R A Feldman
Journal:  J Infect Dis       Date:  1974-05       Impact factor: 5.226

3.  Trends in disease caused by Neisseria meningitidis: 1972 and 1973.

Authors:  J B McCormick; R E Weaver; C Thornsberry; R A Feldman
Journal:  J Infect Dis       Date:  1974-08       Impact factor: 5.226

4.  Prevention of meningococcal disease by group C polysaccharide vaccine.

Authors:  M S Artenstein; R Gold; J G Zimmerly; F A Wyle; H Schneider; C Harkins
Journal:  N Engl J Med       Date:  1970-02-19       Impact factor: 91.245

5.  Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants.

Authors:  R Gold; M L Lepow; I Goldschneider; T L Draper; E C Gotschlich
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

6.  Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age.

Authors:  H Peltola; H Mäkelä; H Käyhty; H Jousimies; E Herva; K Hällström; A Sivonen; O V Renkonen; O Pettay; V Karanko; P Ahvonen; S Sarna
Journal:  N Engl J Med       Date:  1977-09-29       Impact factor: 91.245

7.  An epidemic of disease due to serogroup B Neisseria meningitidis in Alabama: report of an investigation and community-wide prophylaxis with a sulfonamide.

Authors:  J A Jacobson; T J Chester; D W Fraser
Journal:  J Infect Dis       Date:  1977-07       Impact factor: 5.226

8.  Quantitative determination of the human immune response to immunization with meningococcal vaccines.

Authors:  E C Gotschlich; M Rey; R Triau; K J Sparks
Journal:  J Clin Invest       Date:  1972-01       Impact factor: 14.808

9.  A controlled field trial of a serogroup A meningococcal polysaccharide vaccine.

Authors:  M H Wahdan; F Rizk; A M el-Akkad; A A el-Ghoroury; R Hablas; N I Girgis; A Amer; W Boctar; J E Sippel; E C Gotschlich; R Triau; W R Sanborn; B Cvjetanović
Journal:  Bull World Health Organ       Date:  1973-06       Impact factor: 9.408

10.  Human immunity to the meningococcus. I. The role of humoral antibodies.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  15 in total

Review 1.  Safety of hepatitis B, pneumococcal polysaccharide and meningococcal polysaccharide vaccines in pregnancy: a systematic review.

Authors:  Marinos C Makris; Konstantinos A Polyzos; Michael N Mavros; Stavros Athanasiou; Petros I Rafailidis; Matthew E Falagas
Journal:  Drug Saf       Date:  2012-01-01       Impact factor: 5.606

2.  Meningococcal antibody titres in infants of women immunised with meningococcal polysaccharide vaccine during pregnancy.

Authors:  T J O'Dempsey; T McArdle; S J Ceesay; O Secka; E Demba; W A Banya; N Francis; B M Greenwood
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-01       Impact factor: 5.747

Review 3.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

4.  Prevention of neonatal tetanus.

Authors:  W P Glezen
Journal:  Am J Public Health       Date:  1998-06       Impact factor: 9.308

5.  HIV, Cytomegalovirus, and Malaria Infections during Pregnancy Lead to Inflammation and Shifts in Memory B Cell Subsets in Kenyan Neonates.

Authors:  Kee Thai Yeo; Paula Embury; Timothy Anderson; Peter Mungai; Indu Malhotra; Christopher King; James Kazura; Arlene Dent
Journal:  J Immunol       Date:  2019-01-23       Impact factor: 5.422

Review 6.  Meningococcal vaccines. Current status and future possibilities.

Authors:  H Peltola
Journal:  Drugs       Date:  1998-03       Impact factor: 9.546

7.  In utero exposure to helminth and mycobacterial antigens generates cytokine responses similar to that observed in adults.

Authors:  I Malhotra; J Ouma; A Wamachi; J Kioko; P Mungai; A Omollo; L Elson; D Koech; J W Kazura; C L King
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

8.  Prevalence of neutralizing antibody to respiratory syncytial virus in sera from mothers and newborns residing in the Gambia and in The United States.

Authors:  R O Suara; P A Piedra; W P Glezen; R A Adegbola; M Weber; E K Mulholland; B M Greenwood; H Whittle
Journal:  Clin Diagn Lab Immunol       Date:  1996-07

Review 9.  Neonatal infection with Neisseria meningitidis: analysis of a 97-year period plus case study.

Authors:  Evrim Kiray Baş; Ali Bülbül; Serdar Cömert; Sinan Uslu; Selda Arslan; Asiye Nuhoglu
Journal:  J Clin Microbiol       Date:  2014-07-16       Impact factor: 5.948

Review 10.  Meningococcal vaccination in pregnancy.

Authors:  Bahaa Abu Raya; Manish Sadarangani
Journal:  Hum Vaccin Immunother       Date:  2018-03-21       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.